|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Department of Veterans Affairs |
| Information provided by: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00013247 |
Purpose
Due to the disputed efficacy of prostate cancer (CaP) screening and treatment, most authorities recommend that providers inform and involve patients in CaP screening decisions.
| Condition | Intervention |
|
Prostate Cancer |
Behavioral: Prostate Cancer Screening Education |
| MedlinePlus related topics: | Cancer Prostate Cancer |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Single Blind, Active Control, Single Group Assignment, Efficacy Study |
| Official Title: | Facilitating Shared Decisionmaking About Prostate Cancer Screening |
| Estimated Enrollment: | 1152 |
| Study Completion Date: | December 2002 |
| Arms | Assigned Interventions |
| 1 | Behavioral: Prostate Cancer Screening Education |
Background:
Due to the disputed efficacy of prostate cancer (CaP) screening and treatment, most authorities recommend that providers inform and involve patients in CaP screening decisions.
Objectives:
This study evaluated two interventions designed to facilitate this process.
Methods:
1152 male veterans age 50+ with no CaP and primary care appointments at four VA medical facilities in VISN 23 were randomly assigned to one of three groups: mailed pamphlet intervention, mailed video intervention, or usual care (control). Intervention materials were mailed two weeks prior to a target primary care appointment and patient telephone surveys were conducted one week (T1) and one year (T2) after the target appointment. Outcomes included: a 10- item validated knowledge index; responses to questions on CaP natural history, treatment efficacy, PSA accuracy, and expert disagreement about the PSA; whether screening was discussed with provider; scores on decision information seeking, participation and satisfaction scales; screening and treatment preferences; and PSA testing rates.
Status:
Complete
Eligibility
| Ages Eligible for Study: | 50 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patients must be male veterans, age 50 and older, with a scheduled primary care appointment at one of 5 VISN 13 medical facilities. Patients diagnosed with prostate cancer will be excluded.
Exclusion Criteria:
Contacts and Locations
More Information
| Responsible Party: | Department of Veterans Affairs ( Partin, Melissa - Principal Investigator ) |
| Study ID Numbers: | IIR 99-277 |
| First Received: | March 14, 2001 |
| Last Updated: | August 15, 2008 |
| ClinicalTrials.gov Identifier: | NCT00013247 |
| Health Authority: | United States: Federal Government |
|
|